ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 72 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $165,000 | -99.9% | 77,119 | +4.2% | 0.51% | -76.6% |
| Q4 2016 | $326,265,000 | +14.0% | 73,983 | +25.4% | 2.19% | +803.3% |
| Q3 2016 | $286,150,000 | +66.8% | 59,000 | +13.5% | 0.24% | +54.1% |
| Q2 2016 | $171,600,000 | +61.1% | 52,000 | +73.3% | 0.16% | -15.6% |
| Q1 2016 | $106,500,000 | – | 30,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 2,737,140 | $9,033,000 | 7.18% |
| DRILL CRAIG A | 584,600 | $1,929,000 | 3.80% |
| ARMISTICE CAPITAL, LLC | 2,664,000 | $8,791,000 | 3.35% |
| Healthcare Value Capital, LLC | 575,000 | $1,898,000 | 2.30% |
| Tiger Legatus Capital Management, LLC | 1,500,000 | $4,950,000 | 1.50% |
| Broadfin Capital, LLC | 4,106,990 | $13,553,000 | 1.32% |
| Kavi Asset Management, LP | 313,627 | $1,035,000 | 0.83% |
| Elk Creek Partners, LLC | 1,514,918 | $4,999,000 | 0.36% |
| Par Capital Management | 6,400,000 | $21,120,000 | 0.35% |
| Healthcare Value Capital, LLC | 75,000 | $248,000 | 0.30% |